康弘药业：2025年前三季度净利润约10.33亿元

Company Performance - Kanghong Pharmaceutical reported a revenue of approximately 3.624 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 6.23% [1] - The net profit attributable to shareholders of the listed company was about 1.033 billion yuan, showing a year-on-year growth of 6.08% [1] - Basic earnings per share reached 1.12 yuan, which is a year-on-year increase of 5.66% [1] Market Context - As of the report, Kanghong Pharmaceutical has a market capitalization of 29.9 billion yuan [1]